NCT00621244View on ClinicalTrials.gov

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

March 1, 2003

Primary Completion Date

December 3, 2009

Study Completion Date

December 3, 2009

Conditions
LymphomaLeukemiaMultiple Myeloma
Interventions
DRUG

LBH589

Trial Locations (7)

3002

Novartis Investigative Site, Parkville

3181

Novartis Investigative Site, Prahran

30912

Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia, Augusta

55131

Novartis Investigative Site, Mainz

60590

Novartis Investigative Site, Frankfurt/M

77030

MD Anderson Cancer Center/University of Texas, Houston

02115

Dana Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY